Myriad Genetics (MYGN)
(Real Time Quote from BATS)
$28.30 USD
+0.36 (1.29%)
Updated Aug 29, 2024 03:55 PM ET
After-Market: $28.31 +0.01 (0.04%) 4:16 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $0.02 | 16.67% |
Earnings Summary
For their last quarter, Myriad Genetics (MYGN) reported earnings of $0.05 per share, beating the Zacks Consensus Estimate of $-0.01 per share. This reflects a positive earnings surprise of 600.00%. Look out for MYGN's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of $0.02 per share, reflecting a year-over-year increase of 166.67%.
Earnings History
Price & Consensus
Zacks News for MYGN
Should You Hold Hologic (HOLX) Stock in Your Portfolio Now?
MYGN: What are Zacks experts saying now?
Zacks Private Portfolio Services